Abstract
This article examines the ethical issues raised by the pricing of priceless goods. Priceless goods are defined as ones that are widely held to have some special non-market value that makes them unsuited for buying and selling. One subset of priceless goods is prescription drugs-particularly life-saving and life-enhancing ones. Drug makers are under pressure to price their medicines responsibly, which means to restrain their prices (and profits). However, this article argues that it is precisely because life-saving and life-enhancing medicines are priceless that it is especially urgent to leave companies free to charge market prices for them.
Original language | English (US) |
---|---|
Pages (from-to) | 451-480 |
Number of pages | 30 |
Journal | Business Ethics Quarterly |
Volume | 12 |
Issue number | 4 |
DOIs | |
State | Published - Oct 2002 |
Externally published | Yes |